LumiraDx jumps on EU nod for two diagnostic tests

LumiraDx

08/06/2022 15:32

** Shares of diagnostic co LumiraDx Ltd  LMDX.O  jump ~13%
to $4.39
    ** Co receives European CE Mark for two molecular tests, one
helps detect presence of SARS-CoV-2 and another allows
simultaneous detection of influenza A, influenza B, and
SARS-CoV-2  urn:newsml:reuters.com:*:nPn1qSCxVa
    ** CE mark indicates conformity with health, safety and
environmental protection standards for products sold within the
European Economic Area
    ** Tests make results available in 20 minutes - LMDX
    ** Stock down ~51% YTD

 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))